Company News

Lonza and Chr. Hansen Form Microbiome JV

Author Image

By: TOM BRANNA

Editor

SWITZERLAND: Chr. Hansen Holding A/S, a global bioscience company, and Lonza AG have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as a leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture will be an equally-controlled legal entity that will operate from its headquarters in Basel with production facilities in Denmark and Switzerland. The joi...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters